Healthcare entity
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Aiden Doyle, the most common co-covered peer. Abiraterone appears in 1 tracked Healthcare story from July 19, 2026. The tracked stories average 2 original sources each.
Last mentioned: Jul 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Aiden Doyle, the most common co-covered peer. Abiraterone appears in 1 tracked Healthcare story from July 19, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 8 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Abiraterone. Shared-story counts are live from our verified record — not editorial picks.
Second extension announced
Unite confirms the strike has been extended twice, now set to continue through August 7, 2026, bringing total walkout to 65 days.
Strike begins
Staff at the Institute of Cancer Research commence industrial action for the first time in the institute's 117-year history.
The industrial action at the Institute of Cancer Research, originator of Abiraterone, has halted lab work for six weeks and counting, jeopardizing cancer clinical trials and scientific momentum.
Source: yorkpress.co.uk · timesandstar.co.uk
Abiraterone is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
